Neuronal nicotinic receptors as targets for novel analgesics.
about
Functional expression of human α9* nicotinic acetylcholine receptors in X. laevis oocytes is dependent on the α9 subunit 5' UTR.The analgesic and toxic effects of nornicotine enantiomers alone and in interaction with morphine in rodent models of acute and persistent pain.Artemin growth factor increases nicotinic cholinergic receptor subunit expression and activity in nociceptive sensory neurons.Polyethylene glycol-based homologated ligands for nicotinic acetylcholine receptorsPharmacogenetics of new analgesics.The novel small molecule α9α10 nicotinic acetylcholine receptor antagonist ZZ-204G is analgesic.Novel small molecule α9α10 nicotinic receptor antagonist prevents and reverses chemotherapy-evoked neuropathic pain in rats.Positive and negative effects of alcohol and nicotine and their interactions: a mechanistic review.The role of alpha5 nicotinic acetylcholine receptors in mouse models of chronic inflammatory and neuropathic pain.Effects of α7 positive allosteric modulators in murine inflammatory and chronic neuropathic pain models.Pain and suicidality: insights from reward and addiction neuroscience.In vivo pharmacological interactions between a type II positive allosteric modulator of α7 nicotinic ACh receptors and nicotinic agonists in a murine tonic pain model.Tobacco/nicotine and endogenous brain opioids.The nicotinic α6 subunit gene determines variability in chronic pain sensitivity via cross-inhibition of P2X2/3 receptorsThe potential of neuronal nicotinic acetylcholine receptor agonists for treating CNS conditions.Is there a need to identify new anti-emetic drugs?Low concentrations of amitriptyline inhibit nicotinic receptors in unmyelinated axons of human peripheral nerve.Practical total syntheses of epiquinamide enantiomers.Involvement of kappa/dynorphin system in the development of tolerance to nicotine-induced antinociception.Participation of central imidazoline binding sites in antinociceptive effect of ethanol and nicotine in rats.
P2860
Q30454356-F85ABE71-C009-46DE-8618-F41451020C97Q33622522-47608713-9866-47EE-BB9E-D1DFF7365C44Q33677958-C19B5422-4448-4385-A07F-7A972EED612AQ33991497-131E074A-16D8-4E48-A99F-3A707FC35903Q35005640-29B0F15E-D3E9-4B45-9B1B-8843D0793994Q35547518-F1749A2C-0C69-44D8-9307-B84CBFB039D8Q35853738-6DCB4F31-A820-480C-B481-8D7FEF8E791EQ36039402-53878CBB-0D93-4590-AB8E-F98C17235302Q36144723-74447CA4-9328-420B-8D69-304BBE6D9D67Q36463363-F2864B3B-70E8-4296-8096-E38A29302DB3Q36786262-D918FB6F-553F-49FF-BC0E-74E0C0473574Q36929434-724124B0-BB2B-4B00-8DA7-39A24BB6D4F2Q36972568-63CFF81F-25A3-4C5B-9930-5D4CF321ECE8Q37246699-F8AF5329-7C50-4540-A29A-8578AC1E12F7Q38090678-A07182E0-48B9-4AFB-8340-A052A0C0C3AAQ39341803-D4F01E96-DA36-4FD4-9D1D-CB13A0537DE0Q41844707-C8E01A8C-B7C8-4C7E-B926-3D2E63D6D566Q43174687-A0FBE0BC-5D60-40D4-A9C7-B7C53F25D5BBQ46790397-D8CB74E4-8FDD-4FD7-ACCD-3FA8BC0497AAQ51060602-F0672A8D-132E-4393-9061-43F5F5E71C0D
P2860
Neuronal nicotinic receptors as targets for novel analgesics.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Neuronal nicotinic receptors as targets for novel analgesics.
@ast
Neuronal nicotinic receptors as targets for novel analgesics.
@en
Neuronal nicotinic receptors as targets for novel analgesics.
@nl
type
label
Neuronal nicotinic receptors as targets for novel analgesics.
@ast
Neuronal nicotinic receptors as targets for novel analgesics.
@en
Neuronal nicotinic receptors as targets for novel analgesics.
@nl
prefLabel
Neuronal nicotinic receptors as targets for novel analgesics.
@ast
Neuronal nicotinic receptors as targets for novel analgesics.
@en
Neuronal nicotinic receptors as targets for novel analgesics.
@nl
P2860
P1476
Neuronal nicotinic receptors as targets for novel analgesics.
@en
P2093
Michelle Vincler
P2860
P304
P356
10.1517/13543784.14.10.1191
P407
P577
2005-10-01T00:00:00Z